WHG
BMRN icon

Westwood Holdings Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Westwood Holdings Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,904
Closed -$586K – 563
2022
Q3 		$586K Sell
6,904
-5,832
-46% -$519K 0.01% 357
2022
Q2 		$1.05M Sell
12,736
-76
-0.6% -$6.05K 0.01% 339
2022
Q1 		$988K Sell
12,812
-1,474
-10% -$123K 0.01% 358
2021
Q4 		$1.26M Buy
14,286
+5,906
+70% +$487K 0.01% 333
2021
Q3 		$648K Sell
8,380
-673
-7% -$53.1K 0.01% 365
2021
Q2 		$755K Sell
9,053
-3,938
-30% -$312K 0.01% 362
2021
Q1 		$981K Sell
12,991
-1,604
-11% -$131K 0.01% 344
2020
Q4 		$1.28M Sell
14,595
-656
-4% -$52K 0.01% 319
2020
Q3 		$1.16M Sell
15,251
-907
-6% -$91.8K 0.01% 307
2020
Q2 		$1.99M Buy
16,158
+1,943
+14% +$193K 0.03% 285
2020
Q1 		$1.2M Sell
14,215
-1,858
-12% -$160K 0.02% 301
2019
Q4 		$1.36M Sell
16,073
-200
-1% -$15.1K 0.01% 331
2019
Q3 		$1.1M Sell
16,273
-564
-3% -$43.4K 0.01% 331
2019
Q2 		$1.44M Sell
16,837
-2,027
-11% -$173K 0.02% 329
2019
Q1 		$1.68M Sell
18,864
-189
-1% -$17.5K 0.02% 284
2018
Q4 		$1.62M Sell
19,053
-437
-2% -$41.6K 0.02% 267
2018
Q3 		$1.89M Sell
19,490
-4,053
-17% -$405K 0.02% 273
2018
Q2 		$2.22M Buy
23,543
+6,323
+37% +$554K 0.02% 279
2018
Q1 		$1.4M Buy
+17,220
New +$1.48M 0.01% 306

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westwood Holdings Group's BMRN Position: Q4 2022 in Review

Westwood Holdings Group sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2022, closing a stake of 6,904 shares — an estimated $586K sold.

Westwood Holdings Group first reported a position in BMRN in Q1 2018 and held it in 19 quarters. The position peaked at $2.22M in Q2 2018. 580 funds tracked by Wall St. Rank hold BMRN as of Q4 2022.

  • Westwood Holdings Group reported no remaining BioMarin Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Westwood Holdings Group sold 6,904 BioMarin Pharmaceuticals shares in Q4 2022, an estimated $586K.
  • Westwood Holdings Group first reported a position in BioMarin Pharmaceuticals in Q1 2018 and held it in 19 quarters.
  • Westwood Holdings Group's BioMarin Pharmaceuticals position peaked at $2.22M in Q2 2018.
  • 580 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2022.

Based on Westwood Holdings Group's 13F filing for Q4 2022, filed 14 Feb 2023.